HE-ART
HE-ART
批准号:
10062900
负责人:
金额:
$53.88万
依托单位:
依托单位国家:
英国
项目类别:
EU-Funded
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Air travel is an important supplement to other means of regional transportation and in some regions the only viable solution. However, the regional transport market is highly competitive, and air travel must demonstrate that it can compete with hi-speed trains, cars or coaches. One major issue is the perception of the high CO2 and greenhouse gas (GHG) emissions by planes for these short journeys. Hybridization of the propulsion system enables combining the technical components benefits, thereby achieving an overall efficiency improvement. It is a concept well understood by the general public, due to the hybridization of automobiles, and can bring a real impact on the reduction of GHG emissions. While enabling rather than limiting new sources of energy in aviation, an ambitious path to reduction of greenhouse gases and the pathway to a cleaner and greener aviation for regional flights is built upon three pillars: • Electric hybridization • An ultra efficient turboprop thermal engine • 100% SAF compatibility HE-ART will be a first step on the path to hybridization of regional aircraft and a reduction of up to XX% of GHG. This will be accomplished by achieving a strategic global objective of demonstrating, within 36 months, the viability of a hybrid electric thermal turboprop (e-TP) within the scope of a dedicated integrated ground test demonstrator. HE-ART will build on existing state of the art integrating the following technologies into the demonstrator: • Core thermal engine • Electric motor and power electronics • Gearbox • Propeller • Nacelle and heat exchanger This will be executed in conjunction with the Top-Level Aircraft Requirements that will be defined in parallel Clean Aviation research projects. To ensure that these requirements are met in full, HE-ART brings together the leading engine manufacturers, Rolls Royce and Safran with leading airframers, ATR, Airbus and Leonardo along with key manufacturers and research organisations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
基于机器学习的PLWHA人群ART与血脂异常风险预测的真实世界研究
-
批准号:2026JJ82137
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘晓慧
-
依托单位:
纳米硒-解淀粉芽孢杆菌ART9协同增强艾草抗病性的根际微生态机制
-
批准号:2026JJ90160
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:扶雅芬
-
依托单位:
从精子tsRNA影响子代白色脂肪代谢探讨疏肝补肾毓麟汤在ART中干预的作用及机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
蒿花粉组分Art v 1-6损伤气道上皮屏障、促发过敏性哮喘的机制研究
-
批准号:82370041
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:关凯
-
依托单位:
铝毒通过茉莉酸途径激活水稻关键抗铝毒转录因子ART1功能的机制解析
-
批准号:32300228
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:谢文香
-
依托单位:
慢性HIV感染者ART过程中病毒库在免疫重建中的作用及机制研究
-
批准号:82302511
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:张禄雪
-
依托单位:
ART3通过内质网应激介导特发性炎性肌病肌肉炎症细胞浸润的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:肖亦之
-
依托单位:
男男同性性行为HIV-1 CRF01_AE感染者疾病进展、ART治疗效果与肠道菌群的相互作用研究
-
批准号:81971915
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:王福祥
-
依托单位:
O-GlcNAc糖基化修饰通过代谢重编程抑制ART小鼠胎盘血管生成的机制研究
-
批准号:31801250
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2018
-
负责人:陈书强
-
依托单位:
ART影响印记基因Phlda2表达致胎盘发育及功能异常的机制研究
-
批准号:81671463
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2016
-
负责人:王晓红
-
依托单位: